These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3102144)

  • 21. [Thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in 13 children: a case series].
    Schermer E; Streif W; Genser N; Frühwirth M; Trawöger R; Simma B
    Wien Klin Wochenschr; 2000 Nov; 112(21):927-33. PubMed ID: 11144008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TNK-tPA: a new thrombolytic for treatment of acute myocardial infarction.
    Johnson TJ
    S D J Med; 2000 May; 53(5):185-6. PubMed ID: 10835948
    [No Abstract]   [Full Text] [Related]  

  • 23. A randomised dose ranging study of recombinant tissue plasminogen activator in acute myocardial infarction.
    McNeill AJ; Shannon JS; Cunningham SR; Flannery DJ; Campbell NP; Khan MM; Patterson GC; Webb SW; Adgey AA
    Br Med J (Clin Res Ed); 1988 Jun; 296(6639):1768-71. PubMed ID: 3136831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tissue-type plasminogen activator].
    Turazza FM; Pogna M
    Medicina (Firenze); 1990; 10(1):75-8. PubMed ID: 2116566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous recombinant tissue-type plasminogen activator in acute myocardial infarction.
    Gao R; Chen J; Kou W; Yao K; Xu Y; Lu Z; Yu Q; Tao P; Ma J; Zhu J
    Chin Med Sci J; 1991 Sep; 6(3):132-5. PubMed ID: 1793874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An in vitro study of the effects of t-PA and tranexamic acid on whole blood coagulation and fibrinolysis.
    Godier A; Parmar K; Manandhar K; Hunt BJ
    J Clin Pathol; 2017 Feb; 70(2):154-161. PubMed ID: 27445340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal dosage regimens of tissue-type plasminogen activator.
    Agnelli G; Hirsh J
    Semin Thromb Hemost; 1987 Apr; 13(2):160-2. PubMed ID: 3114884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activator.
    Huber K; Beckmann R; Rauscha F; Probst P; Kaindl F; Binder BR
    Z Kardiol; 1993; 82 Suppl 2():195-200. PubMed ID: 8328203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant tissue plasminogen activator enhances microparticle release from mouse brain-derived endothelial cells through plasmin.
    Garraud M; Khacef K; Vion AC; Leconte C; Yin M; Renard JM; Marchand-Leroux C; Boulanger CM; Margaill I; Beray-Berthat V
    J Neurol Sci; 2016 Nov; 370():187-195. PubMed ID: 27772757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome.
    Sun X; Berthiller J; Derex L; Trouillas P; Diallo L; Hanss M
    J Neurol Sci; 2015 Feb; 349(1-2):77-83. PubMed ID: 25619569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. D-Phe-Pro-Arg-chloromethylketone: its potential use in inhibiting the formation of in vitro artifacts in blood collected during tissue-type plasminogen activator thrombolytic therapy.
    Mohler MA; Refino CJ; Chen SA; Chen AB; Hotchkiss AJ
    Thromb Haemost; 1986 Oct; 56(2):160-4. PubMed ID: 2433785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator (rt-PA) in humans.
    Verstraete M; Bounameaux H; de Cock F; Van de Werf F; Collen D
    J Pharmacol Exp Ther; 1985 Nov; 235(2):506-12. PubMed ID: 4057083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
    Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
    Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic effect on thrombolysis of sequential infusion of tissue-type plasminogen activator (t-PA) single-chain urokinase-type plasminogen activator (scu-PA) and urokinase in the rabbit jugular vein thrombosis model.
    Collen D; Stassen JM; De Cock F
    Thromb Haemost; 1987 Oct; 58(3):943-6. PubMed ID: 3124288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New substances and dosages for thrombolysis in acute myocardial infarct].
    Zeymer U; Neuhaus KL
    Z Kardiol; 1993; 82 Suppl 2():137-41. PubMed ID: 8328192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Procoagulant properties of intravenous staphylokinase versus tissue-type plasminogen activator.
    Okada K; Lijnen HR; Moreau H; Vanderschueren S; Collen D
    Thromb Haemost; 1996 Dec; 76(6):857-9. PubMed ID: 8972000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
    Parise P; Hauert J; Iorio A; Callegari P; Agnelli G
    J Lab Clin Med; 1995 Feb; 125(2):212-21. PubMed ID: 7531212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and systemic effects of tissue-type plasminogen activator in normal subjects.
    Tanswell P; Seifried E; Su PC; Feuerer W; Rijken DC
    Clin Pharmacol Ther; 1989 Aug; 46(2):155-62. PubMed ID: 2503283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of L-arginine on in vitro plasmin-generation and fibrinogenolysis.
    Udvardy M; Posán E; Palatka K; Altorjay I; Harsfalvi J
    Thromb Res; 1997 Jul; 87(1):75-82. PubMed ID: 9253802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.